Page 5 - Staff Statement News Today : Breaking News, Live Updates & Top Stories | Vimarsana

<h2><span style="font-size: small;">Introduction<a name="_ednref1" href="https://www.sec.gov/news/statement/munter-oca-2021-12-06?utm_medium=email&amp;utm_source=govdelivery#_edn1">[1]</a></span></h2> <p><span style="font-size: small;">The events of the past year bring to mind the old saying that &ldquo;change is the only constant in life.&rdquo; Our capital markets continue to evolve and adapt in response to changes in the economic environment, investors&rsquo; needs for new types ...

They put this minority staff statement, attempting to rebut the statement of the -- well he didn't put it off. and then this week, chuck grassley is going to be joining donald trump at a rally in his home state. again, sharing the stage with the man who tried to stab american democracy in the heart. who just yesterday said the real insurrection have not november 3rd, the present election, not on january 6th. we it was lindsey graham, of south carolina, who briefly jumped off those trump train, is right back on it, seeing recently, he hopes trump runs again in 2020. for we've got former ambassa...

The Office of the Chief Accountant of the SEC's Division of Investment Management periodically issues "Dear Chief Financial Officer" letters to help registered investment companies...

Regarding Delayed Filing of Quarterly Report Palo Alto, CA June 4, 2021 -- On April 12, 2021, the Acting Director of the Division of Corporation Finance and Acting Chief Accountant of the U.S. Securities and Exchange Commission (the 'SEC') together issued a statement regarding the accounting and reporting considerations for warrants issued by special purpose acquisition companies entitled 'Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies ('SPACs')' (the 'SEC Staff Statement'). As previously disclosed, given the...

European Biotech Acquisition Corp. Receives Expected Notification from Nasdaq Related to Delayed Quarterly Report European Biotech Acquisition Corp. (the "Company") today announced it received a notice on May 28, 2021 from the Nasdaq Stock Market LLC ("Nasdaq") indicating that as a result of the Company's failure to timely file its Quarterly Report on Form 10-Q for the period ended March 31, 2021 (the "Quarterly Report"), the Company no longer complies with the continued listing requirements set forth in Nasdaq Listing Rule 5250(c)(1). The notice has no immediate impact on the listing of the ...